MIPS Molecular Imaging Program at Stanford

Huaijun Wang

Back to Profile

Publication Details

  • Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging.

    De Saint-Hubert M, Wang H, Devos E, Vunckx K, Zhou L, Reutelingsperger C, Verbruggen A, Mortelmans L, Ni Y, Mottaghy FM. Mol Imaging Biol. 2011; 13 (5): 995-1002

    Early after therapy, 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG) imaging is not always reliable due to the influx of inflammatory cells while apoptosis imaging offers a direct and early measurement of therapy effects. This study uses an improved apoptosis probe ((99m)Tc-hAnxA5) in combination with [(18)F]FDG imaging to evaluate therapy response.

    PubMedID: 20848227

Stanford Medicine Resources:

Footer Links: